SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is focused on the rapid and severe value collapse of the memecoin following its launch, which many traders are characterizing as a blatant rug pull. While some participants express amusement or cynicism toward the speculative nature of the token, others are debating whether the price drop presents a potential entry point for a rebound.

iShares Ethereum Trust (The) - iShares Ethereum Trust ETF

iShares Ethereum Trust ETF

The community is discussing iShares Ethereum Trust ETF as a direct way to gain exposure to Ethereum, with traders debating its liquidity and volume benefits compared to other ETH-based products and crypto mining stocks. While some market participants express long-term optimism about Ethereum's role in institutional finance and tokenization, sentiment remains cautious regarding recent price volatility and general market uncertainty.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing active discussion regarding upcoming Q2 earnings, with investors weighing the company's growth catalysts—such as the IHEEZO retina data, BYOOVIZ launch, and VEVYE prescription trends—against past management guidance misses. While sentiment remains divided, many traders maintain a long-term bullish outlook, focusing on potential institutional accumulation and the company's expanding ophthalmic platform despite recent short-term volatility.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

BWET is trending due to surging crude oil tanker shipping rates driven by intense geopolitical tensions and conflict in the Strait of Hormuz. Traders are debating the sustainability of the ETF's parabolic run, with many highlighting its sensitivity to shipping capacity disruptions and geopolitical developments in the Middle East.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Magnificent Seven ETF is trending as traders debate whether the recent underperformance of the group signals a bearish shift or if the collective is nearing a bottoming process. Discussion is largely centered on whether capital is rotating into other sectors or if mega-cap tech will soon resume its leadership role.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer is trending primarily due to the announcement of a definitive agreement to acquire Ratel Robotics for up to $224 million in cash and stock, though traders are debating the potential for share dilution and the impact of an upcoming lock-up expiration.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following an analyst upgrade from UBS, which raised its price target and cited the company's industry-leading unit growth as a primary catalyst. Traders continue to debate the company's valuation against its aggressive expansion plans and long-term potential as a fast-casual leader.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

The stock is trending due to heightened geopolitical tensions in the Middle East following U.S. and Israeli military strikes against Iran, leading traders to anticipate increased government defense spending and contract opportunities for major aerospace and defense primes. Community sentiment remains split between bullish outlooks on the potential for long-term contract growth and bearish caution regarding the sustainability of the current price action given the sector's volatility.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently driven by anticipation surrounding its clinical-stage pipeline, particularly the development of soquelitinib, with traders actively debating the stock's potential for acquisition, upcoming data readouts, and heavy short interest. While bullish investors point to institutional buying and the drug's novel mechanism of action, others express skepticism regarding management's history of delays and the company's long-term path to profitability.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending due to intense community debate over its weak price performance compared to broader crypto markets, with many investors debating whether it is a significant value trap or a long-term buying opportunity given its institutional adoption and real-world asset projects. Traders remain sharply divided, with some betting on a recovery driven by network utility and partnerships, while others express frustration over persistent sell-offs and lack of bullish momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Celularity Stock Gaining Thursday?

Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell Innovations in New Jersey.read more...

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million.
Propanc Biopharma (NASDAQ:PPCB) stock increased byread more...

Mega Movers

The market is getting a fresh reminder that the biggest opportunities are increasingly being built around AI, cybersecurity, advanced medicine and the infrastructure required to commercialize them. Propanc Biopharma (NASDAQ:PPCB), Celularity (NASDAQ:CELU), NeOnc Technologies (NASDAQ:NTHI), Salesforce (NYSE:CRM), CrowdStrike (NASDAQ:CRWD), and Okta (NASDAQ:OKTA).

Celularity’s $300M Manufacturing Opp Could Be a Bigger Deal Than the Headline Suggests

Celularity (NASDAQ:CELU) may have just added a potentially significant new dimension to its cellular-medicine story: manufacturing revenue from a third-party regenerative-medicine platform.

Celularity and MuseCell Innovations Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell Platform

Celularity Inc. (Nasdaq: CELU) (Celularity), a longevity-focused regenerative and cellular medicine company, and MuseCell Innovations Pte. Ltd. (MCI), the owner of the Dezawa MuseCell platform, today announced an additional U.S.-based manufacturing collaboration under which Celularity will...

Celularity (NASDAQ:CELU) Trading 0.4% Higher - Should You Buy?

Celularity (NASDAQ:CELU) Stock Price Up 0.4% - Here's Why...

Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert Joseph Hariri Gordon in 2016 and is headquartered in Florham Park, NJ.

Celularity Inc - Ordinary Shares - Class A

Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$1.41
Prev Close	$1.44
Open	$1.45
Dividend Yield	0.00%
50-Day Moving Average	$0.9473
Beta	1.56
Avg. Volume	11.5M
PE Ratio	-0.39

52-Week High	$2.55
52-Week Low	$0.5601
Market Capitalization	$40.81M
EPS (Annual)	-$3.59
Price to Book	-1.07
Revenue Per Employee	$230,869.57

Feed

News

Sentiment

Earnings

Fundamentals

Info

CELU Fundamentals